AIM
CERE
Anchor Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100
| Closed | -$4.09K | – | 1089 |
|
|
2024
Q2 | $4.09K | Hold |
100
| – | – | ﹤0.01% | 856 |
|
|
2024
Q1 | $4.23K | Hold |
100
| – | – | ﹤0.01% | 879 |
|
|
2023
Q4 | $4.24K | Hold |
100
| – | – | ﹤0.01% | 832 |
|
|
2023
Q3 | $2.18K | Hold |
100
| – | – | ﹤0.01% | 889 |
|
|
2023
Q2 | $3.18K | Hold |
100
| – | – | ﹤0.01% | 863 |
|
|
2023
Q1 | $2.44K | Hold |
100
| – | – | ﹤0.01% | 890 |
|
|
2022
Q4 | $3.15K | Hold |
100
| – | – | ﹤0.01% | 845 |
|
|
2022
Q3 | $2.83K | Hold |
100
| – | – | ﹤0.01% | 864 |
|
|
2022
Q2 | $2.64K | Hold |
100
| – | – | ﹤0.01% | 872 |
|
|
2022
Q1 | $3.5K | Hold |
100
| – | – | ﹤0.01% | 876 |
|
|
2021
Q4 | $3.24K | Hold |
100
| – | – | ﹤0.01% | 909 |
|
|
2021
Q3 | $2.95K | Hold |
100
| – | – | ﹤0.01% | 827 |
|
|
2021
Q2 | $2.56K | Hold |
100
| – | – | ﹤0.01% | 861 |
|
|
2021
Q1 | $1.37K | Buy |
+100
| New | +$1.37K | ﹤0.01% | 904 |
|